If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
118.50    -0.50 (-0.42%)
Bid:
118.00
Ask:
122.00
Spread: 4.00 (3.39%)
Market Cap: £92.99m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Director/PDMR Shareholding

6 May 2026 07:00

RNS Number : 1346D
Xaar PLC
05 May 2026
 

5 May 2026

 

 

Xaar plc

("Xaar", the "Group" or the "Company") 

 

Director/ PDMR Shareholding

 

Xaar the leading inkjet printing technology group, has today been notified of the following transactions in relation to Persons Discharging Managerial Responsibility ("PDMR") in respect of ordinary shares of 10 pence each in the Company ("Shares").

 

1. Grant of Performance Share Awards

On 1 May 2026, the following conditional performance awards were granted to each of John Mills, Chief Executive Officer, Paul James, Chief Financial Officer and Graham Tweedale, Chief Operating Officer under the Xaar 2017 Long Term Incentive Plan ("LTIP"). These conditional awards will vest on the third anniversary of grant at nil cost, subject to the following performance conditions: 60% based on adjusted profit before tax ("PBT") and 40% based on relative total shareholder return ("TSR") measured against the Deutsche Numis Smaller Companies Index (excluding Investment Trusts and Financial Services). For each performance element, 25% of the award will vest for median performance, with full vesting for upper‑quartile performance. Vesting will occur on a straight‑line basis between these points. In addition, the awards are subject to a two‑year post‑vesting holding period.

John Mills

452,583

Paul James

276,132

Graham Tweedale

122,714

 

2. Grant of Deferred Bonus Plan Awards

On the same date, the following awards were granted to each of John Mills and Paul James under the Deferred Bonus Plan ("DBP"). The DBP Awards are due to vest on the second anniversary of grant at nil cost and are not subject to performance conditions:

John Mills

55,194

Paul James

31,250

The preceding five-day average share price, closing on 30 April 2026, of £1.392 was used in determining each of the awards made under the LTIP and DBP.

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

 

John Mills

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Executive Officer and PDMR

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

Xaar Plc

b)

 

LEI

 

213800MXEC3KAOBBPO57

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10p each in Xaar Plc

Identification code

GB0001570810

b)

 

Nature of the transaction

Grant of conditional performance share awards under the Long-Term Incentive Plan (LTIP)

c)

Price(s) and volume(s)

 

 

 

 

Price(s)

Volume(s)

£0

452,583

d)

 

Aggregated information

- Aggregated volume

N/A - single transaction

- Price

e)

 

Date of the transaction

 

1 May 2026

f)

 

Place of the transaction

 

Outside a trading venue

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10p each in Xaar Plc

Identification code

GB0001570810

b)

 

Nature of the transaction

Grant of deferred bonus plan awards under the Deferred Bonus Plan.

c)

Price(s) and volume(s)

 

 

 

 

Price(s)

Volume(s)

£0

55,194

d)

 

Aggregated information

- Aggregated volume

N/A - single transaction

- Price

e)

 

Date of the transaction

 

1 May 2026

f)

 

Place of the transaction

 

Outside a trading venue

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

 

Paul James

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Financial Officer and PDMR

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

Xaar Plc

b)

 

LEI

 

213800MXEC3KAOBBPO57

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10p each in Xaar Plc

Identification code

GB0001570810

b)

 

Nature of the transaction

Grant of conditional performance share awards under the Long-Term Incentive Plan (LTIP)

c)

Price(s) and volume(s)

 

 

 

 

Price(s)

Volume(s)

£0

276,132

d)

 

Aggregated information

- Aggregated volume

N/A - single transaction

- Price

e)

 

Date of the transaction

 

1 May 2026

f)

 

Place of the transaction

 

Outside a trading venue

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10p each in Xaar Plc

Identification code

GB0001570810

b)

 

Nature of the transaction

Grant of deferred bonus plan awards under the Deferred Bonus Plan.

c)

Price(s) and volume(s)

 

 

 

 

Price(s)

Volume(s)

£0

31,250

d)

 

Aggregated information

- Aggregated volume

N/A - single transaction

- Price

e)

 

Date of the transaction

 

1 May 2026

f)

 

Place of the transaction

 

Outside a trading venue

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

 

Graham Tweedale

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Operations Officer and PDMR

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

Xaar Plc

b)

 

LEI

 

213800MXEC3KAOBBPO57

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10p each in Xaar Plc

Identification code

GB0001570810

b)

 

Nature of the transaction

Grant of conditional performance share awards under the Long-Term Incentive Plan (LTIP)

c)

Price(s) and volume(s)

 

 

 

 

Price(s)

Volume(s)

£0

122,714

d)

 

Aggregated information

- Aggregated volume

N/A - single transaction

- Price

e)

 

Date of the transaction

 

1 May 2026

f)

 

Place of the transaction

 

Outside a trading venue

 

Enquiries:

Pheobe Greenwood - Company Secretary

 

Tel: +44 (0) 1223 423 663

E mail: investor.relations@xaar.com

 

Xaar Plc's LEI code is 213800MXEC3KAOBBPO57

 

Classification: 2.2 Information disclosed under article 19 of the Market Abuse Regulation

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFFFELELIEIIR
Date   Source Headline
3rd Feb 20254:15 pmRNSTotal Voting Rights
22nd Jan 202512:30 pmRNSBlock listing Interim Review
21st Jan 20253:00 pmRNSHolding(s) in Company
15th Jan 20257:00 amRNSTrading update & notification of full year results
15th Jan 20257:00 amRNSAppointment of Chief Financial Officer
11th Dec 202410:30 amRNS2024 Full Year Trading Update
4th Dec 202410:45 amRNSUpdate statement on 2024 AGM voting results
3rd Dec 202410:50 amRNSTotal Voting Rights
20th Nov 20247:00 amRNSBoard changes
1st Nov 202412:00 pmRNSTotal Voting Rights
1st Oct 202411:30 amRNSTotal Voting Rights
18th Sep 20247:00 amRNSInterim Results
2nd Sep 20241:45 pmRNSTotal Voting Rights
2nd Aug 20242:30 pmRNSHolding(s) in Company
1st Aug 202411:15 amRNSTotal Voting Rights
30th Jul 20247:00 amRNSNOTICE OF RESULTS AND UPDATE ON TRADING
3rd Jul 202411:45 amRNSBlock listing Interim Review
2nd Jul 20242:00 pmRNSTotal Voting Rights
28th Jun 202410:00 amRNSDirector Declaration
3rd Jun 20242:45 pmRNSTotal Voting Rights
30th May 202412:00 pmRNSBoard changes
29th May 20241:45 pmRNSResult of AGM
29th May 20249:30 amRNSHolding(s) in Company
21st May 20249:30 amRNSDirector/PDMR Shareholding
20th May 20244:30 pmRNSDirector/PDMR Shareholding
13th May 20249:42 amRNSHolding(s) in Company
1st May 20244:15 pmRNSTotal Voting Rights
30th Apr 20244:30 pmRNSDirector/PDMR Shareholding
22nd Apr 202410:51 amRNSAnnual Financial Report
2nd Apr 202412:00 pmRNSTotal Voting Rights
1st Mar 202410:15 amRNSTotal Voting Rights
26th Feb 20249:00 amRNSHolding(s) in Company
23rd Feb 202410:30 amRNSBoard Change
1st Feb 20241:32 pmRNSTotal Voting Rights
29th Jan 202412:04 pmRNSHolding(s) in Company
12th Jan 20243:15 pmRNSBlock listing Interim Review
12th Jan 20247:00 amRNSNotification of Results & Full year Guidance
8th Jan 202412:36 pmRNSTotal Voting Rights
12th Dec 20239:00 amRNSNotification of Transactions of Directors & PDMRs
11th Dec 20233:00 pmRNSNotification of Transactions of Directors & PDMRs
1st Dec 202311:00 amRNSTotal Voting Rights
1st Dec 202310:00 amRNSDirector Declaration
29th Nov 20237:00 amRNSTrading Update
17th Nov 20234:07 pmRNSHolding(s) in Company
9th Nov 20231:53 pmRNSDirector/PDMR Shareholding
3rd Nov 202310:52 amRNSHolding(s) in Company
1st Nov 20234:03 pmRNSTotal Voting Rights
30th Oct 20237:00 amRNSBoard Changes
2nd Oct 202311:45 amRNSTotal Voting Rights
21st Sep 20233:16 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.